Radium 223 works by exploiting its similarity to calcium, which allows it to be incorporated into the bone matrix where cancer cells are prevalent. Once localized in the bone, radium 223 emits alpha particles. These high-energy particles have a short range, which provides a dual benefit: it ensures that the radiation is concentrated in the tumor area and reduces the likelihood of collateral damage to healthy tissues.
